Dabur India Ltd Q4 FY2022 Concall Summary

Key Takeaways

• Revenue crossed ₹10,000 crore in FY22, growing ~14% on the back of a 48% surge in Food & Beverage, but Q4 FMCG volumes contracted 4.1% as high prices and softening demand bit.
• Inflation is not done: management expects another 7–8% inflation in Q1 FY23 on top of last year’s 6–7%, and warns gross margin compression is possible for at least two more quarters.
• Rural demand cracked in Q4 for the first time, with credit cycles doubling to ~20 days and no green shoots visible; downtrading spread to urban India across Hair Oil, Shampoo and Oral Care.
• Healthcare is normalizing, not collapsing: post-COVID seasonality has returned, so Chyawanprash and Honey face a high-base headwind in Q1, but management still targets a double-digit CAGR for the full year.
• What to watch next quarter: whether the promised summer surge in Juices & Nectars materializes, the pace of rural recovery, and if Dabur can take price increases without ceding market share.

Inflation & Margin Pressure

• FY22 inflation hit 12.5%, and calibrated price increases plus cost-saving initiatives only partially offset the damage, leaving consolidated operating profit growth at 12.5% for the year and just 2.5% in Q4.
• Gross margin contracted 130 bps in Q4, driven primarily by the Hair Care category where petroleum-linked inputs and vegetable oil prices surged; Food and Healthcare businesses managed to pass through costs, but Hair Oil could not because of competitive intensity and a deliberate choice to chase market share.
• Inflation is expected to persist at 7–8% in Q1 FY23 on top of last year’s 6–7%, with a full-year FY23 inflation estimate of ~7%; management sees some abatement only in the second half.
• Freight costs jumped more than 20% sequentially, and the Food business’s 12% volume growth in tonnage drove higher absolute freight, while outsourcing of drinks and juices due to capacity shortages pushed up processing charges, all flowing into other expenses.
• Petrol price increases at end-March and early April mean sequentially higher freight inflation is expected over the next two quarters.
• Price increase strategy is deliberately cautious: Dabur is waiting for competitors to move first, which management admits could create near-term margin pressure; if inflation continues, another round of price increases will be unavoidable.

Mohit Malhotra: "I cannot really tell you with confidence that there will be no gross margin compression going forward. At least for two quarters, I think we will have to watch very cautiously, and see if we can take any price increases or cut back on the costs because inflationary environment is just going on and as we speak, the oil is already at 110."

Rural Stress & Downtrading

• Rural demand weakened materially in Q4 after several quarters of outperformance; management flagged liquidity constraints, consumption pressure, and a wallet squeeze, with no green shoots visible at the moment.
• Credit cycles in rural India nearly doubled from ~12 days to ~20 days, a signal management reads as clear compression in consumption, particularly in the Hindi heartland.
• Downtrading is visible across both rural and urban India: low-unit packs at ₹1, ₹5, ₹10, and ₹20 price points are significantly outperforming larger packs across Shampoo, Hair Oil, and Oral Care, with the exception of Ecommerce and modern trade.
• Babool toothpaste is under separate pressure because it indexes heavily to rural India, compounding the broader Oral Care category decline of ~5% in Q4.
• Management expects rural recovery over a six-month horizon, citing a strong summer, good harvest, and predictions of a normal monsoon, but the confidence is a bet rather than a forecast given current liquidity signals.

Mohit Malhotra: "For the first time actually, we are seeing the rural pressure building up, and therefore liquidity constraints in rural, and consumption pressure also and the squeeze in the wallet of the rural consumer."

Category & Portfolio Dynamics

Oral Care

• The toothpaste category declined ~5% in Q4, which management attributes to downtrading and a cutback on consumer promotions due to inflation, not a Dabur-specific issue; Dabur Red grew ~5.6% on a base of ~45% growth last year.
• Herbal category growth is muted because players like Patanjali, Dabur, and Vicco cut back on expenditures due to inflation, reducing the category’s share of voice; Dabur’s value market share stands at ~14.5% and is still gaining.

Mohit Malhotra: "as far as Dabur is concerned, we are not overtly worried, our value market shares are in the range of around 14.5%, and we are into gaining market share. I think Colgate would be more worried on this issue."

Healthcare

• Q4 Healthcare grew 7.4% on a high base of 23%, with Health Supplements up 10%; Chyawanprash gained 250 bps share, Honey 300 bps, and Hajmola 370 bps, while OTC grew 17% led by Dabur Honitus.
• Post-COVID seasonality has returned: Q4 is a non-season for Chyawanprash and Honey, and the early onset of summer plus Omicron-driven pantry loading in Q3 compressed Q4 demand; COVID-era tailwinds that lifted summer sales irrespective of season are gone.
• Q1 FY23 faces a very high base for Chyawanprash, Honey, and contextual products like Tulsi Drops and Health Juices, so a near-term headwind on the Healthcare portfolio is expected; for the full year, management targets a double-digit CAGR.
• Healthcare is expected to settle at ~30% of the portfolio, not because of weakness but because Food and HPC will grow at a higher clip; Food is already inching toward ~19% of the portfolio.

Food & Beverage

• Food & Beverage grew 34% in Q4 and 48% for the full year, driven by strong traction in Drinks and milkshakes; the Juices & Nectars category gained 610 bps market share, and the Food business crossed ₹100 crore in gross sales for the year.
• Summers are protracted and more severe, and the Juices & Nectars and Drinks category is trending very well in April; out-of-home consumption for juices is relatively agnostic to the broader demand slowdown.

HPC & Skincare

• HPC grew only 2% in Q4 on a base of 33% (two-year CAGR 16.2%), with Toothpaste up 11.3% for the full year, Hair Oil up 17.1%, Shampoos up 22%, and Homecare up 21% driven by Odonil, Odomos, and Sanifresh.
• Skincare declined 10.6% in Q4 on a base of ~40%, still delivering an 11% two-year CAGR.
• HPC categories broadly are under pressure: Shampoos, Oral Care, and Hair Oils are all affected by the demand slowdown, while Healthcare and out-of-home juice consumption are relatively insulated.

Channel Shifts

• Ecommerce contributed 6–7% of revenue and performed well, but growth has become muted due to inventory corrections driven by the transition from regular commerce to quick commerce, plus Amazon’s vendor change from Cloudtail causing inventory thinning.
• Muted Ecommerce growth is expected to persist for the next two quarters, with normalization anticipated only in Q2 of the next fiscal year.
• Management’s medium-term ambition is aggressive: Ecommerce contribution is targeted to treble from ~6.5% to 19–20% of total business within four years.
• Innovation in Ecommerce is running at an 11–12% rate, while innovation in General Trade will be calibrated because of high costs; the overall innovation rate target for FY23 is 4–5%.

Mohit Malhotra: "In next four years, we want to see this actually treble in terms of around 19% to 20% of our total business should be coming from Ecommerce, the next four years' time."

International Business

• Constant-currency growth was 10.7% in Q4, with Sub-Sahara Africa up 25%, Egypt up 12%, and Namaste delivering robust double-digit growth; Turkey grew 47% in constant currency but was hammered by a 40% currency devaluation, leading to a consolidated decline of 17% and an ₹85 crore goodwill impairment of Hobi Kozmetik (Hobby Cosmetic).
• MENA region (40–50% of international turnover) is doing exceedingly well with significantly higher profitability, though petroleum-linked inflation is putting pressure on gross margins; management is taking aggressive price increases and targeting double-digit growth in the current year.
• SAARC business is expected to grow almost double-digit next year, and the US business is treading at high single-digit growth in dollar-denominated terms.
• No profit pressures are expected going forward in international markets because per capita incomes are higher, making it easier to pass on inflationary pressures through price increases.

Strategic Initiatives & Capital Allocation

• A greenfield plant in Indore became operational in December 2021, augmenting capacity; India-level CAPEX of ₹400 crore is planned for FY23, including further investment in the Indore facility.
• Cash balance of ~₹6,000 crore is earmarked for acquisitions, with management continuously scouting for synergistic targets in India across Ecommerce, Food, HPC, or Healthcare, waiting for valuations to become more reasonable.
• Innovation commitment remains intact despite margin pressure; management views innovation and renovation as integral to doing business, with new launches including Charcoal Toothpaste on Ecommerce, Chyawanprash extensions into tablets and powder, and Ayush-64 in collaboration with the Ayush Ministry.
• Cost optimization levers are identified if margin pressure intensifies: media spend optimization, employee expense reduction, and cuts to fixed and variable overheads; management’s stated intent is to maintain operating margin.

Mohit Malhotra: "These monies are actually kept for acquisitions basically. So, we are continuously scouting for any synergistic acquisitions in the India business. And as and when the valuations become more reasonable, we want to acquire companies within the space of Ecommerce or which is more synergistic or strategic fit to us."

Guidance & Commitments

Key Metrics